Home > Financial Ratios > MOREPEN LABORATORIES

MOREPEN LABORATORIES
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for MOREPEN LABORATORIES
Please provide your vote to see the results

MOREPEN LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 101.47-45.3620.0567.429.56

What is the latest Core EBITDA Growth ratio of MOREPEN LABORATORIES ?

The latest Core EBITDA Growth ratio of MOREPEN LABORATORIES is 101.47 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024101.47
Mar2023-45.36
Mar202220.05
Mar202167.42
Mar20209.56

How is Core EBITDA Growth of MOREPEN LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2024 101.47
Positive
Mar2023 -45.36
Negative
Mar2022 20.05
-70.26
Mar2021 67.42
605.23
Mar2020 9.56 -

Other Financial Ratios of MOREPEN LABORATORIES


Compare Core EBITDA Growth ratio of peers of MOREPEN LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MOREPEN LABORATORIES ₹3,284.7 Cr -3.2% -3.8% 8.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,551.0 Cr 0.4% 1.8% 4.5% Stock Analytics
DIVIS LABORATORIES ₹175,704.0 Cr -1.1% 0.1% 45.6% Stock Analytics
CIPLA ₹123,675.0 Cr 3.8% 1.2% -1.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,925.0 Cr 2.2% 11.7% 11.7% Stock Analytics
DR REDDYS LABORATORIES ₹106,626.0 Cr 1.4% -3.3% -7.2% Stock Analytics


MOREPEN LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MOREPEN LABORATORIES

-3.2%

-3.8%

8.1%

SENSEX

-0.4%

-1.6%

1.3%


You may also like the below Video Courses